Success Metrics

Clinical Success Rate

50.0%

Based on 1 completed trials

Completion Rate

50%(1/2)

Active Trials

0(0%)

Results Posted

100%(1 trials)

Terminated

1(33%)

Phase Distribution

Ph not_applicable

67%

Ph phase_1

33%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution3 total trials

Phase 1Safety & dosage

1(33.3%)

N/ANon-phased studies

2(66.7%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(1)

Terminated(1)

Other(1)

Detailed Status

Terminated1

Completed1

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

50.0%

Most Advanced

Phase 1

Trials by Phase

Phase 11 (33.3%)

N/A2 (66.7%)

Trials by Status

terminated133%

completed133%

unknown133%

Recent Activity

0 active trials

Showing 3 of 3

completedphase_1

Sphenopalatine Ganglion Block Study

NCT05707754

terminatednot_applicable

Peripherally Inserted Internal Jugular Catheters: an Observational Study

NCT03523533

unknownnot_applicable

Comparison Between Conventional Angiocatheter Versus New Anchoring Device (KARAHOC) Used for Paracentesis

NCT05578573

Clinical Trials (3)

Showing 3 of 3 trials

NCT05707754Phase 1

Sphenopalatine Ganglion Block Study

Completed

NCT03523533Not Applicable

Peripherally Inserted Internal Jugular Catheters: an Observational Study

Terminated

NCT05578573Not Applicable

Comparison Between Conventional Angiocatheter Versus New Anchoring Device (KARAHOC) Used for Paracentesis

Unknown

All 3 trials loaded

Drug Details

Intervention Type: DEVICE
Total Trials: 3